Detailed material

  • Clinical Trial of Inhibition on Digestive Tract Tumor Cell by Tien Hsien Liquid

Research Period: February 1, 2008 – January 31, 2009

Research Topic Research Topic:

An in vitro and in vivo research on controlling MMP-1, MDR-1 and p21 for human colon cancer cell strain HT29 with Tien Hsien Liquid.

Research Conclusion Research Conclusion:

Tien Hsien Liquid may inhibit the growth of tumor and restrain pathological angiogenesis so that it may have the potential to prevent colon lesion but hard to produce drug resistance.

Project Manager Project Manager:

Tong Yao             Dean of School of Chinese Medicine, the University of
                           Hong Kong
                           Medicine PhD of Shanghai University of
                           Traditional Chinese Medicine

Project Implementation Participant Project Implementation Participant:

Stephen C.W. Sze     Lab Director of School of Chinese Medicine, the University
                                of Hong Kong
                                PhD of Anatomy, Chinese University of Hong Kone